Safe Administration of SARS-CoV-2 Vaccine After Desensitization to a Biologic Containing Polysorbate 80 in a Patient With Polyethylene Glycol–Induced Severe Anaphylaxis and Sensitization to Polysorbate 80
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.